Drugs / 1.ALPHA.-HYDROXYVITAMIN D5
1.ALPHA.-HYDROXYVITAMIN D5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01757860 | Sep → Dec 2011 | heart disorder | Cardiavent Inc. | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1.ALPHA.-HYDROXYVITAMIN D5 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297361 ↗ |
| Known as | CARD-024 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01757860 ↗ |
| Known as | LS-144738 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297361 ↗ |
| Known as | MN-201 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297361 ↗ |
| Modality | Small molecule | — CHEMBL4297361 ↗ |
| Route | Oral | “single oral doses of CARD-024” NCT01757860 ↗ |